---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-131777"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2021-10-29T23:59:59+00:00"
generated_at: "2026-06-28T16:06:24.593762+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell Therapeutics appoints Dr. Menghis Bairu to Board; Director Sankesh Abbhi to retire

## Summary
- Bairu appointed to Board effective Oct 28, 2021; receives $30K annual cash award in biannual installments.
- Bairu is founder/CEO of Proxenia Venture Partners and Chairman/CEO of Bairex.
- Abbhi will not stand for re-election at 2021 Annual Meeting; retirement not due to any dispute.
- Abbhi served on Board since March 30, 2020.

## SEC filing metadata
- accession: 0001104659-21-131777
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2021-10-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/tm2131336d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-131777
- JSON: https://secwatch.observer/filing/0001104659-21-131777.json
- Plain text: https://secwatch.observer/filing/0001104659-21-131777.txt

## Key facts
- Executive change
  Menghisteab Bairu was elected as Director at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: elected
  - Role: Director
  source text: the Board of Directors (the “Board”) of Brainstorm Cell Therapeutics Inc. (the “Company”) increased the size of the Board by one member and elected Dr. Menghisteab Bairu to serve as a member of the Board, effective October 28, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm
- Executive change
  Sankesh Abbhi departed as Director at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: not stand for re-election and retire
  - Role: Director
  source text: On October 27, 2021, Sankesh Abbhi informed the Board of his intention not to stand for re-election at the Company’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”), and to retire from the Board effective immediately prior to the commencement of the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465921131777/0001104659-21-131777-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.